Literature DB >> 455444

Genetic control of tumorigenicity in interspecific mammalian cell hybrids.

R Kucherlapati, S I Shin.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 455444     DOI: 10.1016/0092-8674(79)90037-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  7 in total

1.  Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.

Authors:  B C Misra; E S Srivatsan
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

2.  Expression of the alpha subunit of human chorionic gonadotropin is specifically correlated with tumorigenic expression in human cell hybrids.

Authors:  E J Stanbridge; S W Rosen; H H Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 3.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

4.  Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation.

Authors:  A Stoler; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Suppression of malignancy in human cancer cells: issues and challenges.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  A kidney injury molecule-1 (Kim-1) gene reporter in a mouse artificial chromosome: the responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells.

Authors:  Kenji Kokura; Yasushi Kuromi; Takeshi Endo; Naohiko Anzai; Yasuhiro Kazuki; Mitsuo Oshimura; Tetsuya Ohbayashi
Journal:  J Gene Med       Date:  2016-10       Impact factor: 4.565

7.  Tissue preference and differentiation of malignant rat x mouse hybrid cells in chimaeric mouse fetuses.

Authors:  D Duboule; C M Croce; K Illmensee
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.